The Los Angeles Post
California & Local U.S. World Business Lifestyle
Today: February 18, 2025
Today: February 18, 2025
Sriparna  Roy

Sriparna Roy

Staff Writer

Latest From Sriparna Roy

Business|Economy|Finance|Health|Stock Markets

CVS Health tops profit estimates as new CEO pursues turnaround; shares surge

CVS Health beat Wall Street estimates for fourth-quarter profit on Wednesday and provided an annual forecast that largely met expectations, hinting at an

CVS Health tops profit estimates as new CEO pursues turnaround; shares surge
Business|Economy|Finance|Health|Stock Markets

CVS Health's turnaround efforts in focus amid record-high medical costs

CVS Health investors will closely examine this week turnaround initiatives spearheaded by new CEO David Joyner and their impact on cost pressures in its health insurance

CVS Health's turnaround efforts in focus amid record-high medical costs
Business|Economy|Finance|Health|Stock Markets|US

Bristol Myers forecasts steeper drop in 2025 revenue, shares fall

Bristol Myers Squibb on Thursday said its 2025 revenue would fall more sharply than Wall Street had forecast due to generic competition for some of its

Bristol Myers forecasts steeper drop in 2025 revenue, shares fall
Business|Health|US

US FDA approves Vertex's non-opioid painkiller

The U.S.

US FDA approves Vertex's non-opioid painkiller
Business|Health|Political|US

Trump administration withdraws FDA plan to ban menthol cigarettes

The Trump administration has withdrawn a plan to ban menthol cigarettes in the U.S., in a setback to health regulators and activists.

Trump administration withdraws FDA plan to ban menthol cigarettes
Economy|Health|US

US hospitals see post pandemic catch-up behind insurer healthcare costs

Americans are catching up on healthcare missed during the COVID-19 pandemic, a trend driven by heart procedures and outpatient orthopedic surgeries that

US hospitals see post pandemic catch-up behind insurer healthcare costs
Business|Health|Technology

UnitedHealth hack looms over first-quarter earnings report

UnitedHealth is expected to record higher medical costs in its first earnings report since a cyberattack disrupted its technology systems including those that manage

UnitedHealth hack looms over first-quarter earnings report
Health|News|Science|US

US FDA panel votes against Novo Nordisk's weekly insulin in type 1 diabetes patients

Advisers to the U.S. health regulator on Friday voted against the use of Novo Nordisk's weekly insulin in patients with type 1 diabetes due to risks of low

US FDA panel votes against Novo Nordisk's weekly insulin in type 1 diabetes patients
Health|News|Science|US

US FDA staff raises concerns over data from MDMA-based PTSD therapy

The U.S. health regulator's staff said on Friday data on the psychedelic drug MDMA for post-traumatic stress disorder was difficult to interpret, and raised

US FDA staff raises concerns over data from MDMA-based PTSD therapy
US

US FDA approves expanded use of Sarepta's Duchenne gene therapy; shares jump

The U.S.

US FDA approves expanded use of Sarepta's Duchenne gene therapy; shares jump
US

US FDA panel votes against first MDMA-based PTSD treatment

Advisers to the U.S.

US FDA panel votes against first MDMA-based PTSD treatment
Health

Added health benefits of Wegovy, Zepbound could attract more men, doctors say

Evidence that weight-loss drugs like Novo Nordisk's Wegovy and Eli Lilly's Zepbound can cut heart disease risk, treat sleep apnea and address other health

Added health benefits of Wegovy, Zepbound could attract more men, doctors say
Business|Finance|Health|Technology

Boston Scientific to buy Silk Road Medical in $1.16 billion deal

Boston Scientific will buy Silk Road Medical in a $1.16 billion deal, the company said on Tuesday, adding medical devices used for stroke prevention.

Business|Finance|Health|US

Drugmakers kick off industry conference with two cancer deals

Johnson & Johnson and Merck on Monday announced plans to buy cancer therapy developers on the first day of a major U.S. healthcare conference, igniting

Drugmakers kick off industry conference with two cancer deals
Business|Finance|Health|Stock Markets

Lilly beefs up bowel disease drug portfolio with $3.2 billion Morphic deal

Eli Lilly agreed to buy Morphic Holding for $3.2 billion in cash, the companies said on Monday, beefing up its portfolio of inflammatory bowel disease (IBD) drugs and

Lilly beefs up bowel disease drug portfolio with $3.2 billion Morphic deal
Business|News|Science

Musk's Neuralink says tiny wires of brain chip in first patient now stable

The tiny wires of Neuralink's brain chip implant used in the first participant in a trial run by Elon Musk's company have become "more or less very stable", a

Musk's Neuralink says tiny wires of brain chip in first patient now stable
Business|Finance|Technology|US

UnitedHealth expects bigger hit to profit from tech unit hack

UnitedHealth forecast on Tuesday a bigger hit to annual earnings from a February hack at its tech unit, but maintained its full-year profit

UnitedHealth expects bigger hit to profit from tech unit hack
Business|Finance|Health

Health insurer Elevance cautious on Medicaid business this year

Elevance Health signaled medical costs would remain high this year as the insurer expects more claims in the second half from members enrolled in its

Health insurer Elevance cautious on Medicaid business this year
Business|Finance|Health

Health insurer Centene confident about improving costs next year

Centene Corp said on Friday it expects medical costs to improve next year as states catch up with reassessment of enrollments for its Medicaid plans that

Health insurer Centene confident about improving costs next year
Business|Finance|Health

Insurer Humana flags higher medical care use, shares slide

Humana said on Wednesday that demand for medical care was higher than it had anticipated in the second quarter, dampening investor hopes that elevated costs in the Medicare

Insurer Humana flags higher medical care use, shares slide
Business|Finance|Health

CVS Health expects medical costs to remain high through the year

CVS Health said on Wednesday that high demand for medical care among older adults hit second-quarter results, a trend that continued into July,

CVS Health expects medical costs to remain high through the year
News|US

US FDA declines to approve first MDMA-based PTSD treatment

The U.S.

Business|Health|US

Lilly demands doctors stop selling copycat weight-loss drugs

Eli Lilly has sent cease-and-desist letters to U.S. healthcare providers in recent days to stop the promotion of the compounded versions of its drugs

Business|Health

UnitedHealth tech unit's rivals say new, post-hack customers are staying

Smaller rivals to UnitedHealth's tech unit Change Healthcare say they are signing longer-term contracts with hospitals and other customers who had temporarily

UnitedHealth tech unit's rivals say new, post-hack customers are staying
US

US FDA approves Elanco's skin disease treatment for dogs

The U.S.

US FDA approves Elanco's skin disease treatment for dogs

Follow